A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

Surgical resection of head and neck squamous-cell carcinoma (HNSCC) is associated with high rates of local and distant recurrence, partially mitigated by adjuvant therapy. A pre-existing immune response in the patient’s tumor is associated with better outcomes following treatment with conventional t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Sharon, Shay, Baird, Jason R., Bambina, Shelly, Kramer, Gwen, Blair, Tiffany C., Jensen, Shawn M., Leidner, Rom S., Bell, R. Bryan, Casap, Nardy, Crittenden, Marka R., Gough, Michael J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2021
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238246/
https://ncbi.nlm.nih.gov/pubmed/34194619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27982
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak